A Study on the Safety, Tolerability and Pharmacokinetics of WS-0101 Tablets in Chinese Healthy Subjects

NCT06857799 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Healthy Adult Subjects

Interventions

PROCEDURE: Light Power Density and Light Duration 40 mW/cm²*1000s
PROCEDURE: Light Power Density and Light Duration 80 mW/cm²*1000s

Sponsor

Peking University First Hospital